Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

Patient-derived tumour xenografts as models for breast cancer drug development

(2014) Elisabetta Marangoni et al.   CURRENT OPINION IN ONCOLOGY

Up-regulation of the interferon-related genes inBRCA2knockout epithelial cells

(2014) Hong Xu et al.   JOURNAL OF PATHOLOGY

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

(2014) Antonella Sistigu et al.   NATURE MEDICINE

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage

(2013) HyeonJoo Cheon et al.   EMBO JOURNAL

Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model

(2013) Christian Franci et al.   PLoS One

GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer

(2012) Tomohiro Miyake et al.   CANCER SCIENCE

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer

(2012) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer

(2012) F. Andre et al.   CLINICAL CANCER RESEARCH

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts

(2012) A. Romanelli et al.   MOLECULAR CANCER THERAPEUTICS

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

(2012) Justin M Balko et al.   NATURE MEDICINE

Ruxolitinib

(2012) Ruben A. Mesa et al.   NATURE REVIEWS DRUG DISCOVERY

INTERFEROME v2.0: an updated database of annotated interferon-regulated genes

(2012) Irina Rusinova et al.   NUCLEIC ACIDS RESEARCH

The DNA Damage Response Induces IFN

(2011) Sabrina Brzostek-Racine et al.   JOURNAL OF IMMUNOLOGY

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

(2010) L de Plater et al.   BRITISH JOURNAL OF CANCER

Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

(2009) Larissa A. Korde et al.   BREAST CANCER RESEARCH AND TREATMENT

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

(2009) E Marangoni et al.   BRITISH JOURNAL OF CANCER

Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast Carcinoma

(2009) Romain Boidot et al.   CANCER INVESTIGATION

Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy

(2009) Koike Folgueira   ONCOLOGY REPORTS

Chemotherapy-induced tumor gene expression changes in human breast cancers

(2009) Soo-Chin Lee et al.   Pharmacogenetics and Genomics

Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes

(2009) H. Cheon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Roles of unphosphorylated STATs in signaling

(2008) Jinbo Yang et al.   CELL RESEARCH

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY